Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T15:50:13.916Z.
Calculation as of: 2026-10-06T15:50:13.916Z.
Quote observation: 2026-10-06T15:50:08.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 6c856baf2af26ca9326fa79b8c43a58fbb1378fdf70f4049426595b89831cd0b
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Absci Corporation
Market Cap
$1.84B
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.84B
Operating Cash Flow Yield
0.08%
TTM Avg
0.08%
3Y Avg
0.08%
5Y Avg
0.72%
Market Cap
$1.84B
Operating Cash Flow Yield
9.57%
TTM Avg
8.87%
3Y Avg
6.19%
5Y Avg
5.71%
Market Cap
$1.82B
Operating Cash Flow Yield
4.56%
TTM Avg
3.60%
3Y Avg
2.74%
5Y Avg
2.82%
Market Cap
$1.86B
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.88B
Operating Cash Flow Yield
N/A
TTM Avg
0.75%
3Y Avg
4.35%
5Y Avg
3.35%
Market Cap
$1.88B
Operating Cash Flow Yield
2.02%
TTM Avg
4.97%
3Y Avg
3.70%
5Y Avg
3.22%
Market Cap
$1.89B
Operating Cash Flow Yield
0.89%
TTM Avg
1.42%
3Y Avg
1.24%
5Y Avg
1.24%
Market Cap
$1.79B
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Absci Corporation (ABSI) | $1.84B | N/A | N/A | N/A | N/A |
| Novocure Ltd (NVCR)vs › | $1.84B | 0.08% | 0.08% | 0.08% | 0.72% |
| Astrana Health, Inc. (ASTH)vs › | $1.84B | 9.57% | 8.87% | 6.19% | 5.71% |
| LeMaitre Vascular, Inc. (LMAT)vs › | $1.82B | 4.56% | 3.60% | 2.74% | 2.82% |
| Palvella Therapeutics, Inc. (PVLA)vs › | $1.86B | N/A | N/A | N/A | N/A |
| Novavax, Inc. (NVAX)vs › | $1.88B | N/A | 0.75% | 4.35% | 3.35% |
| Azenta, Inc. (AZTA)vs › | $1.88B | 2.02% | 4.97% | 3.70% | 3.22% |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | 0.89% | 1.42% | 1.24% | 1.24% |
| Generate Biomedicines, Inc. (GENB)vs › | $1.79B | N/A | N/A | N/A | N/A |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.89B | N/A | 3.33% | 3.33% | 3.33% |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
